Abstract:Antimicrobial resistance is an increasing global threat, demanding new therapeutic biomolecules against multidrug-resistant bacteria. Antimicrobial peptides (AMPs) are promising candidates for a new generation of antibiotics, but their potential application is still in its infancy, mostly due to limitations associated with large-scale production. The use of recombinant DNA technology for the production of AMPs fused with polymer tags presents the advantage of high-yield production and cost-efficient purification processes at high recovery rates. Owing to their unique properties, we explored the use of an elastin-like recombinamer (ELR) as a fusion partner for the production and isolation of two different AMPs (ABP-CM4 and Synoeca-MP), with an interspacing formic acid cleavage site. Recombinant AMP-ELR proteins were overproduced in Escherichia coli and efficiently purified by temperature cycles. The introduction of a formic acid cleavage site allowed the isolation of AMPs, resorting to a two-step methodology involving temperature cycles and a simple size-exclusion purification step. This simple and easy-to-implement purification method was demonstrated to result in high recovery rates of bioactive AMPs. The minimum inhibitory concentration (MIC) of the free AMPs was determined against seven different bacteria of clinical relevance (Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and two Burkholderia cenocepacia strains), in accordance with the EUCAST/CLSI antimicrobial susceptibility testing standards. All the bacterial strains (except for Pseudomonas aeruginosa) were demonstrated to be susceptible to ABP-CM4, including a resistant Burkholderia cenocepacia clinical strain. As for Synoeca-MP, although it did not inhibit the growth of Pseudomonas aeruginosa or Klebsiella pneumoniae, it was demonstrated to be highly active against the remaining bacteria. The present work provides the basis for the development of an efficient and up-scalable biotechnological platform for the production and purification of active AMPs against clinically relevant bacteria.

Comparison of Antimicrobial Peptide Purification Via Free-Flow Electrophoresis and Gel Filtration Chromatography

Three Methods for Isolation and Analyses of Novel Antibiotics

A Rapid One-Step Process for the Isolation of Antibacterial Peptides by Silica-Decorated Fe3O4nanoparticles

Purification and Characterization of a New Kind of Antimicrobial Peptide by Fungi-Penicillium Sp.m03

Purification Technology and Antimicrobial Activity Analysis of Antimicrobial Peptide from Ovotransferrin

Production and Purification of Two Bioactive Antimicrobial Peptides Using a Two-Step Approach Involving an Elastin-Like Fusion Tag

Strategies for Isolation, Purification and Antimicrobial Antivities Detection of Antimicrobial Peptides from Amphibian Skin

PURIFICATION OF THE ANTIMICROBIAL PEPTIDE AMP- 1 OF CYCLOPELTA PARVA DISTANT BY HPIC

Purification of Low-Abundance Lysozyme in Egg White Via Free-Flow Electrophoresis with Gel-Filtration Chromatography

Screening Lactobacillus producing antimicrobial peptides and study on the separation, purification and characterization of antimicrobial peptides

Purification and characterization of a novel low-molecular-weight antimicrobial peptide produced by Lactiplantibacillus plantarum NMGL2

New Purification Process of Fungal Immunomodulatory Protein, FIP-fve from Flammulina Velutipes Via Filtration and Column Chromatography

A review on the screening methods for the discovery of natural antimicrobial peptides

Expression and Purification of an Antimicrobial Peptide, Bovine Lactoferricin Derivative LfcinB-W10 in Escherichia Coli

Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of α-helix-based peptide amphiphiles.

The Selection of Defoamer for the Antimicrobial Lipopeptide Fermentation by Bacillus Amyloliquefaciens ES-2 and Extraction and Purification of Lipopeptide

Efficient purification of the antimicrobial peptide ε-poly-L-lysine from microbial culture medium with continuous ion-exchange chromatography

Separation and Extraction of Antimicrobial Lipopeptides Produced by Bacillus Amyloliquefaciens ES-2 with Macroporous Resin

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity.

Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33